Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

This publication has 12 references indexed in Scilit:

• Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
  Movement Disorders, 2015
• Peripheral neuropathy associated with levodopa–carbidopa intestinal infusion: a long‐term prospective assessment
  European Journal of Neurology, 2015
• Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program
  Parkinsonism & Related Disorders, 2015
• Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry
  Parkinsonism & Related Disorders, 2015
• Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
  Neurology, 2015
• Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
  The Lancet Neurology, 2014
• Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients
  Journal of Neural Transmission, 2014
• Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens
  Parkinsonism & Related Disorders, 2014
• Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study
  Movement Disorders, 2013
• Neuropathy in Parkinson disease
  Neurology, 2011